Concepedia

Chaitanya Kurhade

CK

Statistics

Publications

24

Citations

1.7K

H-Index

18

Active since

2016

Affiliations

The University of Texas Medical Branch at Galveston(Current)

Pfizer (United States)

Umeå University

BioNTech (Germany)

Helmholtz Centre for Infection Research

Chaitanya Kurhade is an author at The University of Texas Medical Branch at Galveston specializing in infectious diseases, sars-cov-2 infection, and immunology.

ORCID

Publications per year

2016–2023

24

Publications

24

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster

Chaitanya Kurhade, Jing Zou, Hongjie Xia et al. · Nature Medicine · 2022 · 447 citations · Full text

, , +12

Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation

Christakis Panayiotou, Richard Lindqvist, Chaitanya Kurhade et al. · Journal of Virology · 2018 · 156 citations · Full text

, , +16

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

Jing Zou, Hongjie Xia, Xuping Xie et al. · Nature Communications · 2022 · 131 citations · Full text

, , +13

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

Hongjie Xia, Jing Zou, Chaitanya Kurhade et al. · Cell Host & Microbe · 2022 · 109 citations · Full text

, , +11

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions

Yang Liu, Xianwen Zhang, Jianying Liu et al. · Nature Communications · 2022 · 96 citations · Full text

, , +17

1–5 of 24